Real World Evidence

The healthcare system now focuses on being patient centric and this changing trend requires solid framework from RWE. Real-world evidence (RWE) and real-world data (RWD) has rather become a necessity for pharma companies.

RWE – Real World Evidence 

  • LiveTracker™: Structured Real World Evidence data in real-time derived from EMR at the global level.
  • ScanBuzz™: Unstructured RWE data gathered from unbiased patient feedback across all social media platforms.

Our Real World Evidence based solutions

Complete Real World Evidence based solutions analyzing both structured and unstructured data. Real world insights, in real-time.


  • Real-time Real World Evidence based data
  • One online, single-sourced dashboard with multiple levels of access
  • Continuous data collection
  • Accessibility to all data collected: anywhere, anytime
  • Aggregation of data in one mouse click, defining your own views 


  • Real World Evidence social media monitoring
  • Identify overlooked or untouched market segments
  • Understand the patient’s path to purchase
  • Substantiate reasons for prescribing or not prescribing a drug
  • Uncover myths associated with a specific disease

Designed to meet your needs

Latest Technology

  • Data can be analyzed across countries or specialties with the same level of granularity.
  • Continuous data collection, providing live information directly derived from EMR.
  • Downloadable raw data, directly from the dashboard.
  • Completely cloud based with global access

Data QC

  • Quality control performed on a single data source
  • Data never gets copied or transfered
  • High data security, with accesses granted or revoked at a mouse click.

Regulatory Compliance

Real-world evidence (RWE) is considered the medical parallel of big data.  Drugs represent roughly 10 percent of the cost of U.S. healthcare  which projects to $328.6 billion annually. A significant amount from their revenue, $76 billion is spent on global R&D. RWE is as essential for any pharma company as their R&D. Real world evidence can not only provide valuable insights from drug usage and therapies, but also increase revenue stream by aiding the company’s R&D.

We observe an exponential growth of real world evidence in the pharma industry. CEO of Roche Pharmaceuticals, Daniel O’Day quoted to PM live, “regulatory-grade real-world evidence is a key ingredient to accelerate the development of, and access to, new cancer treatments”. Often pharma companies get disheartened when someone else is writing their “story” but they are failing to understand the importance and value of real world evidence. Results of therapies on actual patients truly differ when comparing countries, regions, patient genetics and physicians who are treating them. The era of traditional market research has ended for life sciences industry. With the evolution of technology, we can now have access to continuous real-world data.

The 21st Century Cures Act (Cures Act) was signed into U.S. law on December, 2016. The act is primarily designed to expedite medical product development. It emphasizes on FDA’s continuous goal to incorporate the patients perspectives while pharma companies are developing of drugs. Other legislations are being enacted around the world. While governments are showing keen interest in incorporating patients’ experience, it is crucial that pharma companies invest in real world evidence. Without RWE it is extremely difficult to gain knowledge of the true outcome and experience of the patients.

According to FDA, “we use RWE to monitor post-market safety, adverse event reporting and to make regulatory decisions.” Real world evidence significantly magnifies the patient sample data which was initially tested for therapies during the  clinical trial process. Launch of the drug is no longer the end, but rather the beginning of the race. RWE demonstrates what is happening with real patients in real world after the launch of the drugs. Life science industry can utilize RWE as a significant advantage, as it allows them to gain valuable insights from actual patients from the real world rather than a small sample of patients during clinical trials.

In today’s market, we understand the importance of Real World Evidence. Click below to learn more about our solutions based on RWE.


Continuous tracker
Strategic KPIs
Real time ATU
Tx Sequencing

Monitor Launch in real time


Healthcare Social Media
Monitoring Platform

Gather unbiased customer insight